THQM — Tchaikapharma High Quality Medicines AD Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapHigh Flyer

Market Cap
BGN1.70bn
Enterprise Value
BGN1.71bn
Revenue
BGN53.27m

Annual income statement for Tchaikapharma High Quality Medicines AD, fiscal year end - December 31st, BGN millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	40.4	42.6	43.2	48.6	53.3
Cost of Revenue
Gross Profit	10.4	11.8	12.4	15	17.6
Selling / General / Administrative Expenses
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	39.8	41.1	40.8	44.6	48.1
Operating Profit	0.539	1.46	2.33	3.97	5.17
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	0.624	1.57	3.13	3.87	5.03
Provision for Income Taxes
Net Income After Taxes	0.604	1.4	2.79	3.4	4.49
Net Income Before Extraordinary Items
Net Income	0.604	1.4	2.79	3.4	4.49
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	0.604	1.4	2.79	3.4	4.49
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0	0.001	0.002	0.003	0.047
Dividends per Share